Stay updated on MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial
Sign up to get notified when there's something new on the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page.
Latest updates to the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page
- Check5 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check12 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check48 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check55 days agoChange DetectedThe article on the feasibility and safety of MB-102 in ocular angiography has been updated with a new version dated 2024-11-25, replacing the previous version from 2024-06-25.SummaryDifference0.7%
- Check63 days agoChange DetectedNo new additions were noted, but a significant section of content related to data download options and study details has been removed.SummaryDifference14%
Stay in the know with updates to MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page.